US Bancorp’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-28,986
| Closed | -$685K | – | 4106 |
|
|
2023
Q4 | $685K | Sell |
28,986
-16,071
| -36% | -$380K | ﹤0.01% | 1319 |
|
|
2023
Q3 | $672K | Buy |
+45,057
| New | +$672K | ﹤0.01% | 1220 |
|
|
2023
Q2 | – | Sell |
-360
| Closed | -$3.14K | – | 4113 |
|
|
2023
Q1 | $3.14K | Buy |
+360
| New | +$3.14K | ﹤0.01% | 3641 |
|
|
2021
Q1 | – | Sell |
-1,333
| Closed | -$8K | – | 3939 |
|
|
2020
Q4 | $8K | Buy |
+1,333
| New | +$8K | ﹤0.01% | 3261 |
|
|
2019
Q2 | – | Sell |
-500
| Closed | -$7K | – | 3692 |
|
|
2019
Q1 | $7K | Hold |
500
| – | – | ﹤0.01% | 3162 |
|
|
2018
Q4 | $4K | Buy |
+500
| New | +$4K | ﹤0.01% | 3283 |
|
|
2018
Q3 | – | Sell |
-500
| Closed | -$7K | – | 3719 |
|
|
2018
Q2 | $7K | Buy |
+500
| New | +$7K | ﹤0.01% | 3251 |
|